An article from
News roundup
Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.
Published Sept. 4, 2026
Getty Images
Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.
An article from
News roundup
Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.
Published Sept. 4, 2026
Getty Images

The FDA approves Ionis' Zanvastro as the first treatment for Alexander disease, clearing the way for the company's first solo…

After Jenny Pearson’s daughter Elise first had a seizure at 16 months old, an MRI came back clean—her brain “looked beautiful,”…

Roivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news

After 35 years engaged in the research and development of pharmaceutical products, Ionis began marketing its drugs for the first…

Ionis announces license agreement with Recordati for zilganersen in Alexander disease (AxD) in all countries outside the U.S.

The surprising failure of AstraZeneca and Ionis in a key phase 3 tria | The surprising failure of AstraZeneca and Ionis in a key…